Search Results

Basophil activation in two cases of hydrochlorothiazide-induced noncardiogenic pulmonary edema

Authors: Manso, L.; Heili, S.; Fernández-Nieto, M.; Sastre, B.; Sastre, J.

Source: Allergy, Volume 65, Number 1, January 2010 , pp. 135-136(2)

Publisher: Blackwell Publishing

Irbesartan has no short-term effect on insulin resistance in hypertensive patients with additional cardiometabolic risk factors (i-RESPOND)

Authors: Parhofer, K. G.; Birkeland, K. I.; DeFronzo, R.; Del Prato, S.; Bhaumik, A.; Ptaszynska, A.

Source: International Journal of Clinical Practice, Volume 64, Number 2, January 2010 , pp. 160-168(9)

Publisher: Blackwell Publishing

The Role of Baseline Blood Pressure in Guiding Treatment Choice: A Secondary Analysis of the Use of Valsartan/Hydrochlorothiazide as Initial Therapy in Hypertensive Adults in a Randomized, Double-Blind, Placebo-Controlled Trial

Authors: Pool, James L.; Glazer, Robert; Crikelair, Nora; Levy, Drew

Source: Clinical Drug Investigation, Volume 29, Number 12, 1 December 2009 , pp. 791-802(12)

Publisher: Adis International

Fluoxetine/hydrochlorothiazide: Hyponatraemia?: 2 case reports

Source: Reactions, Volume 1, Number 1277, 2009-11-07 , pp. 22-22(1)

Publisher: Adis International

INVEST revisited: review of findings from the International Verapamil SR-Trandolapril Study

Authors: Cooper-DeHoff, Rhonda M; Handberg, Eileen M; Mancia, Giuseppe; Zhou, Qian; Champion, Annette; Legler, Udo F; Pepine, Carl J

Source: Expert Review of Cardiovascular Therapy, Volume 7, Number 11, November 2009 , pp. 1329-1340(12)

Publisher: Expert Reviews

Valsartan: More Than a Decade of Experience

Authors: Black, Henry R.; Bailey, Jacqueline; Zappe, Dion; Samuel, Rita

Source: Drugs, Volume 69, Number 17, 3 December 2009 , pp. 2393-2414(22)

Publisher: Adis International

Eprosartan: A Review of its Use in Hypertension

Author: Plosker, Greg L.

Source: Drugs, Volume 69, Number 17, 3 December 2009 , pp. 2477-2499(23)

Publisher: Adis International

Diuretic-Induced Potassium Depletion and Glucose Intolerance Are Not Related to Hyperactivity of the Renin-Angiotensin-Aldosterone System in Hypertensive Patients With the Metabolic Syndrome

Authors: Barbieri, Douglas E.; Ribeiro-Filho, Fernando F.; Ribeiro, Artur B.; Zanella, Maria T.

Source: The Journal of Clinical Hypertension, Volume 11, Number 10, October 2009 , pp. 549-554(6)

Publisher: Blackwell Publishing

Use of crospovidone as pelletization aid as alternative to microcrystalline cellulose: effects on pellet properties

Authors: Verheyen, P.; Steffens, K.-J.; Kleinebudde, P.

Source: Drug Development and Industrial Pharmacy, Volume 35, Number 11, November 2009 , pp. 1325-1332(8)

Publisher: Informa Healthcare

Oxcarbazepine/hydrochlorothiazide: SIADH with hyponatraemia in an elderly patient: case report

Source: Reactions, Volume 1, Number 1271, 2009-09-26 , pp. 26-26(1)

Publisher: Adis International

Amlodipine/Valsartan Single-Pill Combination: A Review of its Use in the Management of Hypertension

Authors: Frampton, James E.; Scott, Lesley J.

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 5, 1 October 2009 , pp. 309-330(22)

Publisher: Adis International

Hydrochlorothiazide/indometacin: Paradoxical water intoxication in an infant with nephrogenic diabetes insipidus: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 17-17(1)

Publisher: Adis International

Irbesartan/hydrochlorothiazide/lansoprazole: Severe hyponatraemia (first report for irbesartan) in an elderly patient: case report

Source: Reactions, Volume 1, Number 1273, 2009-10-10 , pp. 19-20(2)

Publisher: Adis International

Effects of low-dose liquorice alone or in combination with hydrochlorothiazide on the plasma potassium in healthy volunteers

Authors: Hukkanen, Janne; Ukkola, Olavi; Savolainen, Markku

Source: Blood Pressure, Volume 18, Number 4, August 2009 , pp. 192-195(4)

Publisher: Informa Healthcare

Drugs with Blocking Effects on the Renin-Angiotensin-Aldosterone System Do Not Improve Endothelial Dysfunction Long-term in Hypertensive Patients

Authors: Sozen, A.B.; Kayacan, M.S.; Tansel, T.; Celebi, A.; Kudat, H.; Akkaya, V.; Erk, O.; Hatipoglu, I.; Demirel, S.

Source: The Journal of International Medical Research, Volume 37, Number 4, July 2009 , pp. 996-1002(7)

Publisher: Field House Publishing

Efficacy and Safety of Long-Term Treatment With the Combination of Amlodipine Besylate and Olmesartan Medoxomil in Patients With Hypertension

Authors: Chrysant, Steven G.; Oparil, Suzanne; Melino, Michael; Karki, Sulekha; Lee, James; Heyrman, Reinilde

Source: The Journal of Clinical Hypertension, Volume 11, Number 9, September 2009 , pp. 475-482(8)

Publisher: Blackwell Publishing

Simultaneous Determination of Losartan and Hydrochlorothiazide in Human Plasma by LC/MS/MS with Electrospray Ionization and Its Application to Pharmacokinetics

Authors: Salvadori, Myriam; Moreira, Roberto; Borges, Bruno; Andraus, Maristela; Azevedo, Cristina; Moreno, Ronilson; Borges, Ney

Source: Clinical and Experimental Hypertension, Volume 31, Number 5, August 2009 , pp. 415-427(13)

Publisher: Informa Healthcare

Valsartan/hydrochlorothiazide: pharmacology and clinical efficacy

Authors: Kondrack, Robyn; Mohiuddin, Syed

Source: Expert Opinion on Drug Metabolism and Toxicology, Volume 5, Number 9, September 2009 , pp. 1125-1134(10)

Publisher: Informa Healthcare

ROLE OF ACTIVATED INTRARENAL REACTIVE OXYGEN SPECIES AND RENIN-ANGIOTENSIN SYSTEM IN IgA NEPHROPATHY MODEL MICE

Authors: Ohashi, Naro; Katsurada, Akemi; Miyata, Kayoko; Satou, Ryousuke; Saito, Toshie; Urushihara, Maki; Kobori, Hiroyuki

Source: Clinical and Experimental Pharmacology and Physiology, Volume 36, Number 8, August 2009 , pp. 750-755(6)

Publisher: Blackwell Publishing

Combination Therapy with Olmesartan Medoxomil and Hydrochlorothiazide: Secondary Analysis of the Proportion of Patients Achieving Recommended Blood Pressure Goals from a Randomized, Double-Blind, Factorial Study

Authors: Chrysant, Steven G.; Chavanu, Kathleen J.; Xu, Jianbo

Source: American Journal of Cardiovascular Drugs, Volume 9, Number 4, 1 August 2009 , pp. 241-251(11)

Publisher: Adis International